{"id":"fresh-frozen-plasma-transfusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Transfusion-related acute lung injury (TRALI)"},{"rate":null,"effect":"Allergic reaction"},{"rate":null,"effect":"Transfusion-associated circulatory overload (TACO)"},{"rate":null,"effect":"Infection transmission risk"},{"rate":null,"effect":"Febrile non-hemolytic transfusion reaction"}]},"_chembl":{"chemblId":"CHEMBL2108772","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FFP is a blood product containing all vitamin K-dependent clotting factors (II, V, VII, X), fibrinogen, and other plasma proteins. It is used to correct multiple factor deficiencies when specific factor replacement is unavailable or impractical. FFP restores coagulation cascade function and improves hemostasis in acute bleeding or surgical settings.","oneSentence":"Fresh frozen plasma transfusion replaces deficient clotting factors and other plasma proteins to restore hemostatic function in patients with coagulopathy or massive bleeding.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:13:26.900Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Massive transfusion / acute hemorrhage with coagulopathy"},{"name":"Multiple clotting factor deficiency"},{"name":"Reversal of warfarin in emergency settings"},{"name":"Thrombotic thrombocytopenic purpura (TTP) plasma exchange"}]},"trialDetails":[{"nctId":"NCT06291025","phase":"NA","title":"Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2024-04-10","conditions":"Thrombotic Microangiopathies","enrollment":131},{"nctId":"NCT02352181","phase":"NA","title":"Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-12","conditions":"Liver Transplantation","enrollment":82},{"nctId":"NCT02750150","phase":"PHASE3","title":"Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2013-07-09","conditions":"Trauma, Coagulopathy","enrollment":42},{"nctId":"NCT04057872","phase":"PHASE1","title":"Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis","status":"COMPLETED","sponsor":"Alberta Health Services, Calgary","startDate":"2020-10-21","conditions":"Septic Shock","enrollment":17},{"nctId":"NCT04074187","phase":"PHASE2, PHASE3","title":"A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-10-21","conditions":"Thrombotic Thrombocytopenic Purpura","enrollment":21},{"nctId":"NCT06403163","phase":"","title":"Transfusion Surveillance in Anaesthesia","status":"RECRUITING","sponsor":"Erasme University Hospital","startDate":"2022-09-01","conditions":"Transfusion Reaction, Transfusion Related Complication, Anesthesia","enrollment":50000},{"nctId":"NCT07127718","phase":"PHASE2","title":"Preventive Strategies for Early and Late Complications of Leptospirosis","status":"RECRUITING","sponsor":"National Kidney and Transplant Institute, Philippines","startDate":"2024-04-12","conditions":"Leptospirosis","enrollment":678},{"nctId":"NCT06144112","phase":"PHASE4","title":"Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery","status":"NOT_YET_RECRUITING","sponsor":"Konkuk University Medical Center","startDate":"2025-09-01","conditions":"Liver Diseases","enrollment":92},{"nctId":"NCT03341156","phase":"PHASE3","title":"Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2018-07-11","conditions":"Heart Disease End Stage, Heart Failure，Congestive","enrollment":14},{"nctId":"NCT04201704","phase":"NA","title":"Effect of Giving Reduced Fluid in Children After Trauma","status":"RECRUITING","sponsor":"Columbia University","startDate":"2018-08-27","conditions":"Critical Illness, Pediatrics, General Surgery","enrollment":250},{"nctId":"NCT05726825","phase":"NA","title":"Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock","status":"RECRUITING","sponsor":"Hannover Medical School","startDate":"2025-02-19","conditions":"Septic Shock","enrollment":274},{"nctId":"NCT05634109","phase":"PHASE3","title":"Whole Blood in Trauma Patients With Hemorrhagic Shock","status":"RECRUITING","sponsor":"Fundacion Clinica Valle del Lili","startDate":"2023-01-14","conditions":"Trauma, Trauma Injury, Trauma, Multiple","enrollment":220},{"nctId":"NCT06021184","phase":"","title":"\"ADE Fibrinogen/RBC\" Ratio on Mortality and Outcome in Massive Transfusion Patients","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2023-11-07","conditions":"Massive Transfusion, Bleeding During/following Surgery","enrollment":1679},{"nctId":"NCT06642493","phase":"NA","title":"Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sheikh Hasina National Institute of Burn and Plastic Surgery","startDate":"2024-05-01","conditions":"Dengue Fever, Dengue Hemorrhagic Fever, Dengue Shock Syndrome","enrollment":300},{"nctId":"NCT06256796","phase":"NA","title":"Fresh Frozen Plasma Transfusion in Acute Organophosphate Poisoning","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2024-08","conditions":"Organophosphorus Poisoning","enrollment":92},{"nctId":"NCT06144099","phase":"PHASE4","title":"Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery","status":"UNKNOWN","sponsor":"Konkuk University Medical Center","startDate":"2024-03-01","conditions":"Prostate Cancer, Spine, Open, Hip Osteoarthritis","enrollment":154},{"nctId":"NCT04107883","phase":"NA","title":"Effect of Transfusion of Plasma on Endothelial During Liver Transplantation","status":"UNKNOWN","sponsor":"Beijing Chao Yang Hospital","startDate":"2023-10-01","conditions":"End Stage Liver DIsease, Liver Transplantation","enrollment":30},{"nctId":"NCT06144125","phase":"PHASE4","title":"Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery","status":"UNKNOWN","sponsor":"Konkuk University Medical Center","startDate":"2024-03-01","conditions":"Cardiac Valve Disease","enrollment":152},{"nctId":"NCT03045068","phase":"PHASE4","title":"Platelet Transfusion During Neonatal Open Heart Surgery","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2017-04-11","conditions":"Cardiac Disease, Cardiac Surgery, Cardiopulmonary Bypass","enrollment":46},{"nctId":"NCT04174989","phase":"NA","title":"Clinical Investigation of Safety and Performance of a Medical Device (ClearPlasma) for the Treatment of Patients With Acute Upper Gastrointestinal Hemorrhage.","status":"COMPLETED","sponsor":"PlasFree Ltd.","startDate":"2020-10-24","conditions":"Acute Upper Gastrointestinal Hemorrhage, Acute Upper Gastrointestinal Bleeding","enrollment":53},{"nctId":"NCT04457349","phase":"NA","title":"Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2020-07-25","conditions":"COVID 19","enrollment":10},{"nctId":"NCT04374539","phase":"PHASE2","title":"Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial","status":"TERMINATED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2020-04-29","conditions":"Coronavirus","enrollment":36},{"nctId":"NCT02784951","phase":"","title":"Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2016-01-01","conditions":"Hemorrhagic Shock","enrollment":72},{"nctId":"NCT04374149","phase":"PHASE2","title":"Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS","status":"COMPLETED","sponsor":"Prisma Health-Upstate","startDate":"2020-04-30","conditions":"Cytokine Release Syndrome, COVID19","enrollment":20},{"nctId":"NCT02647255","phase":"PHASE2, PHASE3","title":"Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy","status":"TERMINATED","sponsor":"Peking University First Hospital","startDate":"2016-03","conditions":"Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency","enrollment":10},{"nctId":"NCT05063409","phase":"NA","title":"Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting","status":"COMPLETED","sponsor":"Shriners Hospitals for Children","startDate":"2010-09","conditions":"Burn Injury","enrollment":72},{"nctId":"NCT03815773","phase":"","title":"PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study","status":"COMPLETED","sponsor":"The Mediterranean Institute for Transplantation and Advanced Specialized Therapies","startDate":"2018-12-01","conditions":"Extracorporeal Membrane Oxygenation Complication, Transfusion Related Complication, Hemorrhage","enrollment":656},{"nctId":"NCT02637427","phase":"PHASE3","title":"Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2016-02-26","conditions":"Blood Coagulation Disorders, Hemorrhage","enrollment":57},{"nctId":"NCT04869072","phase":"PHASE1","title":"Convalescent Plasma Therapy - Zurich Protocol","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2020-04-29","conditions":"COVID-19","enrollment":30},{"nctId":"NCT04547127","phase":"PHASE2","title":"A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)","status":"COMPLETED","sponsor":"Instituto Grifols, S.A.","startDate":"2020-04-29","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04547660","phase":"PHASE3","title":"Convalescent Plasma for Severe COVID-19 Patients","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2020-07-16","conditions":"Covid19","enrollment":160},{"nctId":"NCT04514575","phase":"","title":"Plasma Transfusion in Major Vascular Surgery","status":"COMPLETED","sponsor":"Naestved Hospital","startDate":"1997-01-01","conditions":"Aortic Aneurysm, Abdominal, Arterial Occlusive Diseases","enrollment":17000},{"nctId":"NCT04114643","phase":"PHASE2","title":"Factor Replacement in Surgery","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2019-09-24","conditions":"Bleeding in Cardiac Surgery","enrollment":103},{"nctId":"NCT04485169","phase":"NA","title":"Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;","status":"COMPLETED","sponsor":"UNICEF","startDate":"2020-04-01","conditions":"COVID-19, Cytokine Release Syndrome","enrollment":280},{"nctId":"NCT02460731","phase":"PHASE1","title":"Young Plasma Transfusions for Progressive Supranuclear Palsy","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-05","conditions":"Progressive Supranuclear Palsy","enrollment":6},{"nctId":"NCT04492501","phase":"NA","title":"Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan","status":"COMPLETED","sponsor":"UNICEF","startDate":"2020-04-01","conditions":"Covid19, Cytokine Release Syndrome, Critical Illness","enrollment":600},{"nctId":"NCT02906345","phase":"NA","title":"TPE in Septic Patients and Influence on Organ Failure","status":"UNKNOWN","sponsor":"University of Rostock","startDate":"2016-09","conditions":"Multiple Organ Failure","enrollment":30},{"nctId":"NCT02461251","phase":"NA","title":"Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2016-01","conditions":"Obstetric Labor Complications, Hemorrhage","enrollment":59},{"nctId":"NCT04195282","phase":"NA","title":"RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2019-12","conditions":"Hepatitis B, Acute-On-Chronic Liver Failure","enrollment":20},{"nctId":"NCT02366845","phase":"PHASE4","title":"Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2012-06-27","conditions":"Liver Disease","enrollment":50},{"nctId":"NCT04051437","phase":"PHASE3","title":"Plasma Exchange in Acute on Chronic Liver Failure","status":"UNKNOWN","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2019-08-15","conditions":"Cirrhosis, Liver, Acute-On-Chronic Liver Failure","enrollment":130},{"nctId":"NCT03911037","phase":"PHASE2, PHASE3","title":"GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-05-04","conditions":"Decompensated Cirrhosis of Liver","enrollment":70},{"nctId":"NCT04013113","phase":"NA","title":"Efficacy and Safety of Hemoperfusion or Plasma Exchange Compared to Standard Medical Therapy in Patients With Acute on Chronic Liver Failure","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2019-07-09","conditions":"Acute-On-Chronic Liver Failure","enrollment":250},{"nctId":"NCT01358734","phase":"PHASE2","title":"A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Celgene","startDate":"2012-04-27","conditions":"Acute Myeloid Leukemia, Acute Myelogenous Leukemia","enrollment":88},{"nctId":"NCT01838863","phase":"PHASE2","title":"Control of Major Bleeding After Trauma Study","status":"TERMINATED","sponsor":"Denver Health and Hospital Authority","startDate":"2014-04-07","conditions":"Trauma, Hemorrhagic Shock","enrollment":144},{"nctId":"NCT03282201","phase":"","title":"A Survey on Blood Transfusions in Major Artrhoplasty Operations","status":"COMPLETED","sponsor":"Diskapi Teaching and Research Hospital","startDate":"2017-10-15","conditions":"Arthropathy of Hip, Arthropathy of Knee","enrollment":418},{"nctId":"NCT03275077","phase":"","title":"To Compare TEG (Thrombelastography) and Conventional Tests in CKD Patients","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-03-12","conditions":"End Stage Renal Disease, Coagulopathy","enrollment":100},{"nctId":"NCT02311985","phase":"NA","title":"Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial","status":"TERMINATED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2014-09","conditions":"Liver Cirrhosis","enrollment":57},{"nctId":"NCT03415698","phase":"PHASE2, PHASE3","title":"G-CSF in Decompensated Cirrhosis: an Open Label Trial","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2016-07","conditions":"Cirrhosis, Liver","enrollment":100},{"nctId":"NCT03354559","phase":"","title":"Trauma Associated Bleeding: Effectiveness of an Early Coagulation Support Protocol","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2011-01-01","conditions":"Major Trauma","enrollment":235},{"nctId":"NCT01903863","phase":"NA","title":"The Effect of Prophylactic FFP Administration on ECMO Circuit Longevity","status":"COMPLETED","sponsor":"Duke University","startDate":"2013-07","conditions":"Extracorporeal Membrane Oxygenation","enrollment":31},{"nctId":"NCT01461889","phase":"PHASE3","title":"INR-Triggered Transfusion In GI Bleeders From ER","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2011-07","conditions":"Respiratory Distress Syndrome, Adult, Gastrointestinal Hemorrhage, Liver Diseases","enrollment":50},{"nctId":"NCT01589666","phase":"PHASE1","title":"Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers","status":"COMPLETED","sponsor":"Entegrion, Inc.","startDate":"2013-11","conditions":"Coagulation Defects","enrollment":27},{"nctId":"NCT02416817","phase":"PHASE4","title":"Strategy of Transfusion in Trauma Patients - STATA Trial","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2014-07","conditions":"Wounds and Injuries","enrollment":156},{"nctId":"NCT02845232","phase":"","title":"Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2013-03","conditions":"Acute Myeloid Leukemia","enrollment":214},{"nctId":"NCT02412943","phase":"PHASE1","title":"Pappalysin 2 (PAPP-A2) Enzyme Replacement","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2015-04","conditions":"Short Stature, Idiopathic","enrollment":1},{"nctId":"NCT01471730","phase":"PHASE3","title":"The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery","status":"COMPLETED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2011-11","conditions":"Heart Disease","enrollment":119},{"nctId":"NCT00221741","phase":"","title":"Fresh Frozen Plasma in Cardiac Surgery: Descriptive and Prognostic Study","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2004-02","conditions":"Heart Surgery, Blood Loss, Surgical","enrollment":1497},{"nctId":"NCT01787071","phase":"","title":"Fluid Challenges in Intensive Care","status":"COMPLETED","sponsor":"European Society of Intensive Care Medicine","startDate":"2013-04","conditions":"Focus: Fluid Challenge","enrollment":2304},{"nctId":"NCT00799773","phase":"PHASE3","title":"Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)","status":"TERMINATED","sponsor":"Carelon Research","startDate":"2009-04","conditions":"Thrombotic Thrombocytopenic Purpura","enrollment":3},{"nctId":"NCT01143909","phase":"NA","title":"Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) Patients","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2010-05","conditions":"Blood Coagulation Disorders, Hemorrhage","enrollment":81},{"nctId":"NCT01269138","phase":"","title":"Treatment of Inherited Factor VII Deficiency","status":"COMPLETED","sponsor":"University of L'Aquila","startDate":"2007-01","conditions":"Factor VII Deficiency","enrollment":223},{"nctId":"NCT00968487","phase":"PHASE1","title":"The Safety of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Healthy Volunteers","status":"COMPLETED","sponsor":"HemCon Medical Technologies, Inc","startDate":"2010-06","conditions":"Healthy","enrollment":16},{"nctId":"NCT00945542","phase":"PHASE1, PHASE2","title":"The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study)","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2009-07","conditions":"Hemorrhagic Shock, Trauma Coagulopathy","enrollment":70},{"nctId":"NCT00770718","phase":"PHASE1","title":"Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage","status":"TERMINATED","sponsor":"University of Utah","startDate":"2008-04","conditions":"Intracranial Hemorrhage","enrollment":2},{"nctId":"NCT00953901","phase":"PHASE3","title":"Is Plasma Transfusion Beneficial Prior to Low-Risk Procedures in Hospitalized Patients With Blood Clotting Abnormalities?","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-07","conditions":"Blood Coagulation, Disorders, Surgical Procedures, Minimally Invasive","enrollment":2},{"nctId":"NCT00816127","phase":"NA","title":"Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2003-10","conditions":"Liver Cirrhosis, Coagulopathy","enrollment":36},{"nctId":"NCT00302965","phase":"PHASE1, PHASE2","title":"Effectiveness of Plasma Transfusions in Critical Care Patients","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2005-04","conditions":"Coagulation","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":248,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Fresh frozen plasma transfusion","genericName":"Fresh frozen plasma transfusion","companyName":"Rutgers, The State University of New Jersey","companyId":"rutgers-the-state-university-of-new-jersey","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fresh frozen plasma transfusion replaces deficient clotting factors and other plasma proteins to restore hemostatic function in patients with coagulopathy or massive bleeding. Used for Massive transfusion / acute hemorrhage with coagulopathy, Multiple clotting factor deficiency, Reversal of warfarin in emergency settings.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}